Who is iCAD?

iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.

iCAD’s Response to COVID-19

Read our response to COVID-19 and learn how our portfolio of solutions supporting cancer detection and therapy continue to offer significant benefits to clinicians, patients and the overall healthcare system.

​READ MORE

Recent News

March 31, 2020
iCAD Announces New Credit Facility with Bridge Bank Increasing Operational Flexibility

March 23, 2020
iCAD Launches New Initiatives Leveraging Unique Capabilities of its Robust Product Portfolio to Reduce Health Care System Pressures During the COVID-19 Pandemic

February 27, 2020
iCAD Reports Fourth Quarter and Full-Year 2019 Financial Results

February 13, 2020
iCAD to Report Fourth Quarter 2019 Financial Results on Thursday, February 27, 2020

February 12, 2020
iCAD to Participate in the 40th Annual Cowen Healthcare Conference

CONNECT

© 2018, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.